Karyopharm Therapeutics Inc. (30) | Intellectual Property (1)

Browse by Subcategory

License Agreements (1)

Recent Contracts

Amendment to License Agreement, dated May 1, 2020, by and between Antengene Therapeutics Limited and the Registrant (Filed With SEC on August 4, 2020)